A detailed history of Black Rock Inc. transactions in Alpha Teknova, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 37,191 shares of TKNO stock, worth $287,486. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,191
Previous 35,097 5.97%
Holding current value
$287,486
Previous $93,000 46.24%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.29 - $2.81 $2,701 - $5,884
2,094 Added 5.97%
37,191 $50,000
Q1 2024

May 10, 2024

SELL
$2.41 - $3.88 $5,875 - $9,459
-2,438 Reduced 6.5%
35,097 $93,000
Q4 2023

Feb 13, 2024

SELL
$1.85 - $3.73 $7,113 - $14,341
-3,845 Reduced 9.29%
37,535 $140,000
Q3 2023

Nov 13, 2023

SELL
$1.66 - $3.83 $929 - $2,144
-560 Reduced 1.34%
41,380 $115,000
Q2 2023

Aug 11, 2023

SELL
$1.8 - $3.98 $556,705 - $1.23 Million
-309,281 Reduced 88.06%
41,940 $111,000
Q1 2023

May 12, 2023

SELL
$2.74 - $6.25 $28,553 - $65,131
-10,421 Reduced 2.88%
351,221 $1.04 Million
Q4 2022

Feb 13, 2023

SELL
$3.23 - $5.64 $164,077 - $286,500
-50,798 Reduced 12.32%
361,642 $2.04 Million
Q3 2022

Nov 14, 2022

SELL
$3.34 - $9.2 $18,066 - $49,762
-5,409 Reduced 1.29%
412,440 $1.38 Million
Q2 2022

Aug 12, 2022

SELL
$6.39 - $16.24 $1,111 - $2,825
-174 Reduced 0.04%
417,849 $3.51 Million
Q1 2022

May 12, 2022

SELL
$12.79 - $21.64 $77,967 - $131,917
-6,096 Reduced 1.44%
418,023 $5.77 Million
Q4 2021

Feb 10, 2022

BUY
$17.49 - $26.72 $1.75 Million - $2.68 Million
100,223 Added 30.94%
424,119 $8.69 Million
Q3 2021

Nov 09, 2021

BUY
$17.47 - $27.49 $2.69 Million - $4.24 Million
154,190 Added 90.86%
323,896 $8.06 Million
Q2 2021

Aug 11, 2021

BUY
$23.73 - $27.98 $4.03 Million - $4.75 Million
169,706 New
169,706 $4.03 Million

Others Institutions Holding TKNO

About Alpha Teknova, Inc.


  • Ticker TKNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 28,080,500
  • Market Cap $217M
  • Description
  • Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...
More about TKNO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.